hbr.org/2019/08/hire-l…

European Society of Cardiology Journals pascal vranckx Christiaan JM Vrints Very nice editorial and interesting new issue!
Congratulations and good luck to pascal vranckx for this important milestone.
Sure that he with the new editorial team will do a fantastic job for the journal and all the readers!

16. We hope you enjoyed this #EHJACVC tweetorial. Big thank you to Twitter Editors Konstantin Krychtiuk María Rubini rafavidalperez Ümit Yaşar Sinan 👏

Now you're set to start #ACVC2021 in top form😉

Susanna Price Milica Aleksic MIЯVΛƬ #IC Professor Vijay Kunadian Mihai Trofenciuc Pablo Jorge #ACVC_ESC

15. The issue is completed by an important #COVID19 paper:
A study from Wuhan showed that peak levels of high sensitive troponin I and not admission levels predict in-hospital mortality in #COVID_19 patients with cardiac injury academic.oup.com/ehjacc/article…

#EHJACVC

14. The third one is an excellent young #ACVC_ESC initiative evaluating the current status of #AcuteCardiovascularCare training in Europe:
Current status and needs for changes in critical care training: the voice of the young cardiologists academic.oup.com/ehjacc/article…

#EHJACVC

13. The second position paper deals with the composition, structure and function of the #HeartTeam : a joint position paper of European Society of Cardiology #ACVC_ESC #EAPCI EACTS and @EACTA focusing on the patient with complex CAD requiring revascularisation academic.oup.com/ehjacc/article…

#EHJACVC

12. The issue also features three excellent reviews and position papers:

The first one is a comprehensive educational review on cardiac tamponade - from pathophysiology and diagnosis to pericardiocentesis academic.oup.com/ehjacc/article…

#EHJACVC

11. What is the prognostic relevance of pericardial effusion (PE) in #STEMI treated with pPCI?
In a large registry study from Italy, PE was not associated with mortality. Free wall rupture is rare but more frequent in patients with PE academic.oup.com/ehjacc/article…

#EHJACVC

10. In this French analysis, Renaudier et al. showed that 14 of 150 VA- #ECMO patients suffered from acute mesenteric ischemia, with a 100% mortality. Risk factors included RRT and second shock, early enteral nutrition was protective academic.oup.com/ehjacc/article…

#EHJACVC

9. In an IABP-SHOCK-II subanalysis, G Fürnau and Holger Thiele studied timing of IABP implantation.
They could show no outcome difference in #AMICS patients whether IABP was implanted pre or post pPCI academic.oup.com/ehjacc/article…

#EHJACVC

8. Elena Collado et al. analysed the hospitalisation-related economic impact of patients with #CardiogenicShock in a reference centre.
Economic cost was significant, but with a low ratio of cost per life-year gained academic.oup.com/ehjacc/article…

#EHJACVC

7.What's the long-term prognosis after AMI- #CardiogenicShock ? A markedly ⬆️ rate of #HeartFailure hospitalisation & 1-yr mortality is the paramount finding of this study.
But among 1-yr survivors of MI, remaining 5-yr mortality was similar with/without CS
academic.oup.com/ehjacc/article…

4. In the Spanish 5-center Red-Shock cohort, Mercedes Rivas-Lasarte et al. provide external validation and comparison of the #CardShock and IABP-SHOCK II risk scores.
The authors demonstrate both were good predictors of in-hospital mortality in ACS-related CS academic.oup.com/ehjacc/article…

3. In an editorial titled 'Potential growth in cardiogenic shock research though an international registry collaboration', Sean van Diepen and Dave Morrow call for a Hub-of-Spokes model in #CardiogenicShock research academic.oup.com/ehjacc/article…

#EHJACVC #CardioEd

1. Hot off the press - #EHJACVC Issue 1/2021 tweetorial 🔽

The issue opens with an editorial by new EiC pascal vranckx, highlighting the aims of the journal, presenting the new editorial board and thanking Christiaan JM Vrints, former EiC academic.oup.com/ehjacc/article…

#ACVC_ESC #cardiotwitter

hbr.org/2021/02/dont-u…

hbr.org/2020/11/how-to…

Now in EHJ: Acute Cardiovascular Care. More data on the use of intravenous beta-blockers in STEMI.
IV Beta-blockers in STEMI patients with KILLIP class<3 in the acute phase is associated with a significant reduction in malignant arrhythmias without increase in cardiogenic shock.

In het kader van Hulp aan de Natie Medical Component Be zal opnieuw beademingstoestellen leveren aan Jessa Ziekenhuis zodat zij kunnen opschalen naar Fase 2b 👍pascal vranckx @GenNeirinckx FOD Volksgezondheid #teamwork #alltogether 🤜🤜🤜 #Respect

Scientists warn of new coronavirus variant spreading across Europe ft.com/content/278265… via @financialtimes